During the past decade, Gifu Heart Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gifu Heart Center" #1 sponsor was "Aarhus University Hospital Skejby" with 1 trials, followed by "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored, "Bayer" with 1 trials sponsored, "CathWorks Ltd." with 1 trials sponsored and "Seoul National University Hospital" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gifu Heart Center" #1 collaborator was "Gifu Heart Center" with 2 trials as a collaborator, "Inje University" with 2 trials as a collaborator, "Keimyung University Dongsan Medical Center" with 2 trials as a collaborator, "Samsung Medical Center" with 2 trials as a collaborator and "Ulsan University Hospital" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Gifu Heart Center" are "Coronary Artery Disease" (4 trials), "Coronary Stenosis" (2 trials), "Atrial Fibrillation" (1 trials), "Cardiac Ischemia" (1 trials) and "Microvascular Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Gifu Heart Center" in a lesser frequency.

Most popular intervention types in "Gifu Heart Center" are "Diagnostic Test" (3 trials), "Other" (2 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "FFRangio" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gifu Heart Center" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Gifu Heart Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Gifu Heart Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gifu Heart Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".